Effects of metformin phonophoresis and exercise therapy on pain, range of motion, and physical function in chronic knee osteoarthritis: randomized clinical trial.


Journal

Journal of orthopaedic surgery and research
ISSN: 1749-799X
Titre abrégé: J Orthop Surg Res
Pays: England
ID NLM: 101265112

Informations de publication

Date de publication:
26 Oct 2024
Historique:
received: 06 04 2024
accepted: 26 09 2024
medline: 26 10 2024
pubmed: 26 10 2024
entrez: 25 10 2024
Statut: epublish

Résumé

Knee osteoarthritis (KOA) is a common musculoskeletal disorder. Therapeutic ultrasound (US) is a safe and effective treatment for KOA. It relieves knee pain and enhances function. Metformin (MF) regulates chondrocytes, hence providing chondroprotection. Furthermore, it efficiently reduces knee articular cartilage degeneration and retards the progression of osteoarthritis. However, the localized administration of MF by phonophoresis for KOA has yet to be studied. To assess the possible effects of metformin phonophoresis (MFPH) plus exercise therapy (EX) compared to MFPH alone or the US on knee pain, function, and range of motion (ROM) in chronic KOA patients. Seventy-eight patients with unilateral mild to moderate chronic KOA were included. Patients were randomly assigned to three groups: group A (MFPH + EX), group B (MFPH alone), and group C (US). The US group used an acoustic-neutral gel, while the MFPH group used a gel containing 1.2% MF. The exercises included hamstring stretches, calf stretches, and knee strengthening exercises. Treatment in the three groups continued for four weeks (three sessions per week). The Visual Analog Scale (VAS), the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and the goniometer were used to assess knee pain, function disability, and ROM, respectively. All measures were recorded before, 2 weeks, and 4 weeks after the intervention in all groups. Multivariate Analysis of Variance (MNOVA) was performed to compare the effects within and between groups for knee ROM and function disability. The Kruskal-Wallis test and the Friedman test analyzed the pain intensity. When the baseline patient characteristics were compared, there were no significant differences in means of age, gender, body mass index (BMI), or lower limb dominance across the three groups (p > 0.05). After 4 weeks of intervention, clinical outcomes significantly improved in all three groups (p < 0.05). However, patients in the MFPH + EX group improved significantly in all outcomes compared to the MFPH and US groups (p < 0.05). Post-treatment results showed a statistically and clinically significant improvement in pain intensity, knee ROM, and function in the MFPH group; however, combining MFPH with exercises is more beneficial in reducing KOA symptoms. Clinical Trial Registry at (pactr.samrc.ac.za) database. NO: PACTR202311507335269. Date: November 9, 2023 (retrospectively registered).

Sections du résumé

BACKGROUND BACKGROUND
Knee osteoarthritis (KOA) is a common musculoskeletal disorder. Therapeutic ultrasound (US) is a safe and effective treatment for KOA. It relieves knee pain and enhances function. Metformin (MF) regulates chondrocytes, hence providing chondroprotection. Furthermore, it efficiently reduces knee articular cartilage degeneration and retards the progression of osteoarthritis. However, the localized administration of MF by phonophoresis for KOA has yet to be studied.
PURPOSE OBJECTIVE
To assess the possible effects of metformin phonophoresis (MFPH) plus exercise therapy (EX) compared to MFPH alone or the US on knee pain, function, and range of motion (ROM) in chronic KOA patients.
METHODS METHODS
Seventy-eight patients with unilateral mild to moderate chronic KOA were included. Patients were randomly assigned to three groups: group A (MFPH + EX), group B (MFPH alone), and group C (US). The US group used an acoustic-neutral gel, while the MFPH group used a gel containing 1.2% MF. The exercises included hamstring stretches, calf stretches, and knee strengthening exercises. Treatment in the three groups continued for four weeks (three sessions per week). The Visual Analog Scale (VAS), the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and the goniometer were used to assess knee pain, function disability, and ROM, respectively. All measures were recorded before, 2 weeks, and 4 weeks after the intervention in all groups. Multivariate Analysis of Variance (MNOVA) was performed to compare the effects within and between groups for knee ROM and function disability. The Kruskal-Wallis test and the Friedman test analyzed the pain intensity.
RESULTS RESULTS
When the baseline patient characteristics were compared, there were no significant differences in means of age, gender, body mass index (BMI), or lower limb dominance across the three groups (p > 0.05). After 4 weeks of intervention, clinical outcomes significantly improved in all three groups (p < 0.05). However, patients in the MFPH + EX group improved significantly in all outcomes compared to the MFPH and US groups (p < 0.05).
CONCLUSION CONCLUSIONS
Post-treatment results showed a statistically and clinically significant improvement in pain intensity, knee ROM, and function in the MFPH group; however, combining MFPH with exercises is more beneficial in reducing KOA symptoms.
TRIAL REGISTRATION BACKGROUND
Clinical Trial Registry at (pactr.samrc.ac.za) database. NO: PACTR202311507335269. Date: November 9, 2023 (retrospectively registered).

Identifiants

pubmed: 39456024
doi: 10.1186/s13018-024-05120-0
pii: 10.1186/s13018-024-05120-0
doi:

Substances chimiques

Metformin 9100L32L2N

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

689

Informations de copyright

© 2024. The Author(s).

Références

Primorac D, Molnar V, Rod E, Jeleč Ž, Čukelj F, Matišić V, Vrdoljak T, Hudetz D, Hajsok H, Borić I. Knee osteoarthritis: A review of pathogenesis and state-of-the-art non-operative therapeutic considerations. In Genes. 2020; 11(8):854; https://doi.org/10.3390/genes11080854
Kloppenburg M, Berenbaum F. Osteoarthritis year in review 2019: epidemiology and therapy. Osteoarthr Cartil. 2020;28(3):242–8. https://doi.org/10.1016/j.joca.2020.01.002 .
doi: 10.1016/j.joca.2020.01.002
Milaras C, Lepetsos P, Dafou D, Potoupnis M, Tsiridis E. Association of Matrix Metalloproteinase (MMP) gene polymorphisms with knee osteoarthritis: a review of the literature. Cureus. 2021;13(10). https://doi.org/10.7759/cureus.18607 .
Abramoff B, Caldera FE, Osteoarthritis. Pathology, diagnosis, and Treatment options. Med Clin North Am. 2020;104(2):293–311. https://doi.org/10.1016/j.mcna.2019.10.007 .
doi: 10.1016/j.mcna.2019.10.007 pubmed: 32035570
Arden NK, Perry TA, Bannuru RR, Bruyère O, Cooper C, Haugen IK, Hochberg MC, McAlindon TE, Mobasheri A, Reginster JY. Non-surgical management of knee osteoarthritis: comparison of ESCEO and OARSI 2019 guidelines. Nat Rev Rheumatol. 2020;17(1). https://doi.org/10.1038/s41584-020-00523-9 .
Moseng T, Vliet Vlieland TPM, Battista S, Beckwée D, Boyadzhieva V, Conaghan P, Costa D, Doherty M, Finney AG, GeorgievT, Gobbo M, Kennedy N, Kjeken I, Kroon FPB, Lohmander LS, Lund H, Mallen CD, Pavelka K, Pitsillidou IA, Rayman MP. Østerås N. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update annals of the Rheumatic diseases 2024; 83(6), 730–40. https://doi.org/10.1136/ard-2023-225041
Zeng CY, Zhang ZR, Tang ZM, Hua FZ. Benefits and mechanisms of Exercise training for knee osteoarthritis. Front Physiol. 2021;12(1). https://doi.org/10.3389/fphys.2021.794062 .
Garber CE, Blissmer B, Deschenes MR, et al. Quantity and quality of Exercise for developing and maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in apparently healthy adults. Med Sci Sports Exerc. 2011;43(7):1334–59. https://doi.org/10.1249/mss.0b013e318213fefb .
doi: 10.1249/mss.0b013e318213fefb pubmed: 21694556
Baker KG, Robertson VJ, Duck FA. A review of therapeutic ultrasound: biophysical effects. Phys Ther. 2001;81(7):1351–8.
doi: 10.1093/ptj/81.7.1351 pubmed: 11444998
Yeğin T, Altan L, Kasapoğlu Aksoy M. The Effect of Therapeutic Ultrasound on Pain and physical function in patients with knee osteoarthritis. Ultrasound Med Biol. 2017;43(1):187–94. https://doi.org/10.1016/j.ultrasmedbio.2016.08.03511 .
doi: 10.1016/j.ultrasmedbio.2016.08.03511 pubmed: 27727020
Cakir S, Hepguler S, Ozturk C, Korkmaz M, Isleten B, Atamaz FC. Efficacy of therapeutic Ultrasound for the management of knee osteoarthritis. Am J Phys Med Rehabil. 2014;93(5):405–12. https://doi.org/10.1097/phm.0000000000000033 .
doi: 10.1097/phm.0000000000000033 pubmed: 24322433
Said Ahmed MA, Saweeres ESB, Abdelkader NA, Abdelmajeed SF, Fares AR. Improved pain and function in knee osteoarthritis with dexamethasone phonophoresis: a randomized controlled trial. Indian J Orthop. 2019;53(6):700. https://doi.org/10.4103/ortho.ijortho_639_18 .
doi: 10.4103/ortho.ijortho_639_18 pubmed: 31673169 pmcid: 6804376
Deniz S, Topuz O, Atalay NS, Sarsan A, Yildiz N, Findikoglu G, Karaca O, Ardic F. Comparison of the effectiveness of pulsed and continuous Diclofenac Phonophoresis in treatment of knee osteoarthritis. J Phys Therapy Sci. 2009;21(4):331–6. https://doi.org/10.1589/jpts.21.3311 .
doi: 10.1589/jpts.21.3311
Kozanoglu E, Basaran S, Guzel R, Guler-Uysal F. Short term efficacy of ibuprofen phonophoresis versus continuous ultrasound therapy in knee osteoarthritis. Swiss Med Wkly. 2003;133(23–24):333–8. https://doi.org/10.4414/smw.2003.10210 .
doi: 10.4414/smw.2003.10210 pubmed: 12923684
Luksurapan W, Boonhong J. Effects of Phonophoresis of Piroxicam and Ultrasound on symptomatic knee osteoarthritis. Arch Phys Med Rehabil. 2013;94(2):250–5. https://doi.org/10.1016/j.apmr.2012.09.025 .
doi: 10.1016/j.apmr.2012.09.025 pubmed: 23063790
Na HS, Kwon JY, Lee SY, Lee SH, Lee AR, Woo JS, Jung K, Cho KH, Choi JW, Lee DH, Min HK, Park SH, Kim SJ, Cho ML. Metformin attenuates Monosodium-Iodoacetate-Induced Osteoarthritis via Regulation of Pain mediators and the autophagy-lysosomal pathway. Cells. 2021;10(3):681. https://doi.org/10.3390/cells10030681 .
doi: 10.3390/cells10030681 pubmed: 33808727 pmcid: 8003384
Wang Y, Zhao X, Lotz M, Terkeltaub R, Liu-Bryan R. Mitochondrial biogenesis is impaired in osteoarthritis chondrocytes but reversible via peroxisome proliferator-activated receptor γ coactivator 1α. Arthritis Rheumatol. 2015;67(8):2141–53. https://doi.org/10.1002/art.39182 .
doi: 10.1002/art.39182 pubmed: 25940958 pmcid: 4519411
Najeeb S, Zafar MS, Khurshid Z, Zohaib S, Madathil SA, Mali M, Almas K. Efficacy of metformin in the management of periodontitis: a systematic review and meta-analysis. Saudi Pharm J. 2018;26(5):634–42. https://doi.org/10.1016/j.jsps.2018.02.029 .
doi: 10.1016/j.jsps.2018.02.029 pubmed: 29991907 pmcid: 6035318
Pradeep AR, Patnaik K, Nagpal K, Karvekar S, Ramamurthy BL, Naik SB, Suke D, Singh P, Raju A. Efficacy of locally-delivered 1% metformin gel in the treatment of intrabony defects in patients with chronic periodontitis: a randomized, controlled clinical trial. J Investig Clin Dent. 2016;7(3):239–45. https://doi.org/10.1111/JICD.12150 .
doi: 10.1111/JICD.12150 pubmed: 25787121
Veronese N, Koyanagi A, Stubbs B, Cooper C, Guglielmi G, Rizzoli R, Punzi L, Rogoli D, Caruso MG, Rotolo O, Notarnicola M, Al-Daghri N, Smith L, Reginster JY, Maggi S. Mediterranean diet and knee osteoarthritis outcomes: a longitudinal cohort study. Clin Nutr. 2019;38(6):2735–9. https://doi.org/10.1016/j.clnu.2018.11.032 .
doi: 10.1016/j.clnu.2018.11.032 pubmed: 30553579
Ruan G, Yuan S, Lou A, Mo Y, Qu Y, Guo D, Guan S, Zhang Y, Lan X, Luo J, Mei Y, Zhang H, Wu W, Dai L, Yu Q, Cai X, Ding C. Can metformin relieve tibiofemoral cartilage volume loss and knee symptoms in overweight knee osteoarthritis patients? Study protocol for a randomized, double-blind, and placebo-controlled trial. BMC Musculoskelet Disord. 2022;23(1):486. https://doi.org/10.1186/s12891-022-05434-2 .
doi: 10.1186/s12891-022-05434-2 pubmed: 35598008 pmcid: 9124394
Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, Callahan L, Copenhaver C, Dodge C, Felson D, Gellar K, Harvey WF, Hawker G, Herzig E, Kwoh CK, Nelson AE, Samuels J, Scanzello C, White D, Wise B, Altman RD, DiRenzo D, Fontanarosa J, Giradi G, Ishimori M, Misra D, Shah AA, Shmagel AK, Thoma LM, Turgunbaev M, Turner AS, Reston J. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, hip, and Knee. Arthritis Rheumatol. 2020;72(2):220–33. https://doi.org/10.1002/art.41142 .
doi: 10.1002/art.41142 pubmed: 31908163 pmcid: 10518852
Skou ST, Koes BW, Grønne DT, Young J, Roos EM. Comparison of three sets of clinical classification criteria for knee osteoarthritis: a cross-sectional study of 13,459 patients treated in primary care. Osteoarthr Cartil. 2020;28(2):167–72. https://doi.org/10.1016/J.JOCA.2019.09.003 .
doi: 10.1016/J.JOCA.2019.09.003
World Medical Association Declaration of Helsinki. JAMA. 2013;310(20):2191–4. https://doi.org/10.1001/JAMA.2013.281053 . : ethical principles for medical research involving human subjects.
Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M, Howell D, Kaplan D, Koopman W, Longley S, Mankin H, McShane DJ, Medsger T, Meenan R, Mikkelsen W, Moskowitz R, Murphy W, Rothschild B, Segal M, Sokoloff L, Wolfe F. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29(8):1039–49. https://doi.org/10.1002/ART.1780290816 .
doi: 10.1002/ART.1780290816 pubmed: 3741515
Ravaud P, Giraudeau B, Auleley GR, Chastang C, Poiraudeau S, Ayral X, Dougados M. Radiographic assessment of knee osteoarthritis: reproducibility and sensitivity to change. J Rheumatol. 1996;23(10):1756–64.
pubmed: 8895154
Baldassari S, Solari A, Zuccari G, Drava G, Pastorino S, Fucile C, Marini V, Daga A, Pattarozzi A, Ratto A, Ferrari A, Mattioli F, Barbieri F, Caviglioli G, Florio T. Development of an Injectable slow-release metformin formulation and evaluation of its potential Antitumor effects. Sci Rep 2018 8:1, 8(1), 1–12. https://doi.org/10.1038/s41598-018-22054-w
Alghadir AH, Anwer S, Iqbal A, Iqbal ZA. Test-retest reliability, validity, and minimum detectable change of visual analog, numerical rating, and verbal rating scales for measurement of osteoarthritic knee pain. J Pain Res 2018 26; 11:851–6. https://doi.org/10.2147/JPR.S158847
Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833–40.
pubmed: 3068365
Alghadir A, Anwer S, Iqbal ZA, Alsanawi HA. Cross-cultural adaptation, reliability, and validity of the arabic version of the reduced Western Ontario and McMaster universities osteoarthritis index in patients with knee osteoarthritis. Disabil Rehabil. 2016;38(7):689–94. https://doi.org/10.3109/09638288.2015.1055380 .
doi: 10.3109/09638288.2015.1055380 pubmed: 26066566
Castle H, Kozak K, Sidhu A, Khan RJK, Haebich S, Bowden V, Fick DP, Goonatillake H. Smartphone technology: a reliable and valid measure of knee movement in knee replacement. Int J Rehabil Res. 2018;41(2):152–8. https://doi.org/10.1097/MRR.0000000000000276 .
doi: 10.1097/MRR.0000000000000276 pubmed: 29465474
Knapp PW, Keller RA, Mabee KA, Shi J, Pillai R, Frisch NB. Comparison of a smartphone app to manual knee range of motion measurements. Arthroplasty Today. 2022;15:43–6. https://doi.org/10.1016/j.artd.2021.09.005 .
doi: 10.1016/j.artd.2021.09.005 pubmed: 35399987 pmcid: 8987335
Li H, Ding X, Terkeltaub R, Lin H, Zhang Y, Zhou B, He K, Li K, Liu Z, Wei J, Yang Y, Xie H, Zeng C, Lei G. Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior. Arthritis Res Therapy. 2020;22(1). https://doi.org/10.1186/S13075-020-2129-Y .
Schadler P, Lohberger B, Stündl N, Stradner MH, Glänzer D, Sadoghi P, Leithner A, Steinecker-Frohnwieser B. The Effect of Body Mass Index and Metformin on Matrix Gene expression in arthritic primary human chondrocytes. Cartilage. 2021;13(2suppl):S1004–18. https://doi.org/10.1177/1947603520962558 .
Wang Y, Hussain SM, Wluka AE, Lim Y, Abram F, Pelletier JP, Martel-Pelletier J, Cicuttini FM. Association between metformin use and disease progression in obese people with knee osteoarthritis: Data from the Osteoarthritis Initiative - A prospective cohort study. Arthritis Res Therapy,2019; 21(1), 1–6. https://doi.org/10.1186/S13075-019-1915-X/TABLES/2
Pandey A, Kumar VL. Protective effect of metformin against Acute inflammation and oxidative stress in rat. Drug Dev Res. 2016;77(6):278–84. https://doi.org/10.1002/DDR.21322 .
doi: 10.1002/DDR.21322 pubmed: 27510757
Zhang J. Meta-analysis of serum C-reactive protein and cartilage oligomeric matrix protein levels as biomarkers for clinical knee osteoarthritis. BMC Musculoskelet Disord. 2018;19(1). https://doi.org/10.1186/S12891-018-1932-Y .
Mohammed M, Al-shamma K, Jasim NA. Evaluation of the anti-inflammatory effect of metformin as adjuvant therapy to NSAID (meloxicam) in patients with knee osteoarthritis. Int J Sci Nat. 2014;23(2):277–82.
Raposo F, Ramos M, Lúcia Cruz A. Effects of exercise on knee osteoarthritis: a systematic review. Musculoskelet Care. 2021;19(4):399–435. https://doi.org/10.1002/msc.1538 .
doi: 10.1002/msc.1538
Yang FA, Chen HL, Peng CW, Liou TH, Escorpizo R, Chen HC. A systematic review and meta-analysis of the effect of phonophoresis on patients with knee osteoarthritis. Sci Rep. 2022;12(1). https://doi.org/10.1038/s41598-022-16084-8 .
Martin-Vega FJ, Lucena-Anton D, Galán-Mercant A, Perez-Cabezas V, Luque-Moreno C, Vinolo-Gil MJ, Gonzalez-Medina G. (2022). Phonophoresis through nonsteroidal anti-inflammatory drugs for knee osteoarthritis treatment: systematic review and Meta-analysis. Biomedicines,2022;10(12)3254. https://doi.org/10.3390/biomedicines10123254
Byl NN. The use of ultrasound as an enhancer for transcutaneous drug delivery: phonophoresis. Phys Ther. 1995;75(6):539–53. https://doi.org/10.1093/ptj/75.6.539 .
doi: 10.1093/ptj/75.6.539 pubmed: 7770499
Pinkaew D, Kiattisin K, Wonglangka K, Awoot P. Phonophoresis of Phyllanthus amarus nanoparticle gel improves functional capacity in individuals with knee osteoarthritis: a randomized controlled trial. J Bodyw Mov Ther. 2020;24(1):15–8. https://doi.org/10.1016/J.JBMT.2019.04.013 .
doi: 10.1016/J.JBMT.2019.04.013 pubmed: 31987536
Akinbo S, Owoeye O, Adesegun S. Comparison of the therapeutic efficacy of Diclofenac Sodium and Methyl Salicylate Phonophoresis in the management of knee osteoarthritis. Archives Rheumatol. 2011;26(2):111–9. https://doi.org/10.5606/TJR.2011.017 .
doi: 10.5606/TJR.2011.017
Boyaci A, Tutoglu A, Boyaci N, Aridici R, Koca I. Comparison of the efficacy of ketoprofen phonophoresis, ultrasound, and short-wave diathermy in knee osteoarthritis. Rheumatol Int. 2013;33(11):2811–8. https://doi.org/10.1007/s00296-013-2815-z .
doi: 10.1007/s00296-013-2815-z pubmed: 23832291
Oktayoǧlu P, Gür A, Yardimeden I, Çaǧlayan M, Çevik F, Bozkurt M, Em S, Uçar D, Nas K. Comparison of the efficacy of phonophoresis and conventional ultrasound therapy in patients with primary knee osteoarthritis. Erciyes Tip Dergisi. 2014;36(1):11–8. https://doi.org/10.5152/etd.2013.64 .
doi: 10.5152/etd.2013.64
Toopchizadeh V, Javadi R, Sadat BE. Therapeutic efficacy of Dexamethasone Phonophoresis on symptomatic knee osteoarthritis in Elderly Women. Int J Women’s Health Reprod Sci. 2014;2(3):168–77. https://doi.org/10.15296/ijwhr.2014.25 .
doi: 10.15296/ijwhr.2014.25
Joshi MV, Phansopkar P. Effect of Zingiber Cassumunar Roxb. Phonophoresis Versus Aqua Sonic Gel on Pain, Range of Motion, and functional disability in patients with osteoarthritis of knee: a Randomized Controlled Trial. Cureus. 2022;14(12):e32760. https://doi.org/10.7759/cureus.32760 .
doi: 10.7759/cureus.32760 pubmed: 36686146 pmcid: 9852679

Auteurs

Marwah Salih Abed (MS)

Department of Physical Therapy for Musculoskeletal Disorders and its Surgeries, Faculty of Physical Therapy, Cairo University, Cairo, Egypt.

Marihan Zakaria Aziz (MZ)

Department of Physical Therapy for Musculoskeletal Disorders and its Surgeries, Faculty of Physical Therapy, Cairo University, Giza, Egypt. marihan_aziz@cu.edu.eg.
Department of Physical Therapy for Musculoskeletal Disorders, and its Surgeries, Faculty of Physical El Maadi, Cairo, Egypt. marihan_aziz@cu.edu.eg.

Nabil Mohie AbdelHamid (NM)

Faculty of Pharmacy, Kafrelsheikh University, Kafr Elsheikh, Egypt.

Elsadat Saad Soliman (ES)

Department of Physical Therapy for Musculoskeletal Disorders and its Surgeries, Faculty of Physical Therapy, Cairo University, Cairo, Egypt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH